Lauren Morris - Medpace Holdings Associate Relations
MEDP Stock | USD 389.27 0.92 0.24% |
Insider
Lauren Morris is Associate Relations of Medpace Holdings
Phone | 513 579 9911 |
Web | https://www.medpace.com |
Medpace Holdings Management Efficiency
The company has return on total asset (ROA) of 0.1389 % which means that it generated a profit of $0.1389 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.6135 %, meaning that it created $0.6135 on every $100 dollars invested by stockholders. Medpace Holdings' management efficiency ratios could be used to measure how well Medpace Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Michael MBA | Natera Inc | 44 | |
Olesya CPA | Natera Inc | N/A | |
John Abbott | Castle Biosciences | N/A | |
Camilla Zuckero | Castle Biosciences | N/A | |
Rishi Kacker | Natera Inc | N/A | |
Eric Evans | Natera Inc | N/A | |
Marica Grskovic | Caredx Inc | N/A | |
Marcel Konrad | Caredx Inc | 48 | |
Pamela Wong | Myriad Genetics | 56 | |
Clivetty Martinez | Myriad Genetics | N/A | |
Nicole Lambert | Myriad Genetics | 50 | |
Jonathan MEng | Natera Inc | 51 | |
Dale Muzzey | Myriad Genetics | 44 | |
Andy Ament | Guardant Health | N/A | |
Michael Bell | Guardant Health | 55 | |
Douglas Jones | Neogen | 54 | |
Sasha MBA | Caredx Inc | 38 | |
Domitille Bigot | Mettler Toledo International | 48 | |
Thomas Theuringer | Qiagen NV | N/A | |
Julie Mann | Neogen | 59 | |
RN RN | Castle Biosciences | 56 |
Management Performance
Return On Equity | 0.61 | ||||
Return On Asset | 0.14 |
Medpace Holdings Leadership Team
Elected by the shareholders, the Medpace Holdings' board of directors comprises two types of representatives: Medpace Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medpace. The board's role is to monitor Medpace Holdings' management team and ensure that shareholders' interests are well served. Medpace Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medpace Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Susan Burwig, Senior Vice President - Operations | ||
Kevin Brady, CFO Treasurer | ||
Brandon Ebken, Chief Officer | ||
August MD, Chairman CEO | ||
Stephen JD, General Officer | ||
Stephen Ewald, General Counsel, Corporate Secretary | ||
Todd Meyers, Vice Marketing | ||
Reinilde MD, Chief Department | ||
Weimin MS, VP Biometrics | ||
Daniel OLeary, VP Department | ||
John MBA, Senior Unit | ||
MA BSN, Executive Operations | ||
CPA BBA, President | ||
Lauren Morris, Associate Relations |
Medpace Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medpace Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.61 | ||||
Return On Asset | 0.14 | ||||
Profit Margin | 0.16 % | ||||
Operating Margin | 0.20 % | ||||
Current Valuation | 11.81 B | ||||
Shares Outstanding | 30.98 M | ||||
Shares Owned By Insiders | 17.88 % | ||||
Shares Owned By Institutions | 82.72 % | ||||
Number Of Shares Shorted | 942.77 K | ||||
Price To Earning | 49.07 X |
Medpace Holdings Investors Sentiment
The influence of Medpace Holdings' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Medpace. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Medpace Holdings' public news can be used to forecast risks associated with an investment in Medpace. The trend in average sentiment can be used to explain how an investor holding Medpace can time the market purely based on public headlines and social activities around Medpace Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Medpace Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Medpace Holdings' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Medpace Holdings' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Medpace Holdings.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medpace Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medpace Holdings' short interest history, or implied volatility extrapolated from Medpace Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Medpace Stock analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.